Efficacy and acceptability of a new emotional and social mind group training programme for bulimia nervosa

A preliminary randomised controlled trial of the efficacy and acceptability of a new emotional and social mind group training programme versus standard cognitive behavioural group therapy for bulimia nervosa

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN61115988

Enrollment

Registered

2009-05-29

Start date

2009-04-20

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bulimia nervosa (BN)/eating disorder not otherwise specified (EDNOS) Mental and Behavioural Disorders Eating disorders

Interventions

Group 1: Emotional and social mind training (ESM) - Patients in this group will receive a 17-session treatment (4 individual sessions, 12 group sessions, 1 follow-up session). The individual sessions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients referred to the South London and Maudsley Eating Disorder Service who fully (bulimia nervosa [BN]) or partially (eating disorder not otherwise specified [EDNOS]) fulfil Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for bulimia nervosa 2. Outpatients 3. Male or female 4. Aged 18 - 65 years

Exclusion criteria

Exclusion criteria: 1. Insufficient knowledge of English or literacy levels to allow understanding of the intervention materials 2. Active suicidality 3. Severe substance dependence 4. Diabetes 5. Pregnancy 6. Received Maudsley Model treatment for eating disorder within last 12 months

Design outcomes

Primary

Measure	Time frame
Core bulimic symptomology (bingeing, purging, etc.) measured by the Eating Disorders Examination (EDE) at baseline (pre-treatment), 4 months (end of treatment) and 6 months (follow-up).	—

Secondary

Measure	Time frame
1. Symptoms of depression, anxiety and stress, respectively, measured by the Depression Anxiety and Stress Scales (DASS-21). 21 items, each scored 0 - 3, giving total score of 0 - 63. Comprised of 3 scales (7 items each) for depression, anxiety and stress scoring 0 - 21, respectively. For each item score represents 0 (no symptom at all), 1 (symptom present to some degree, or some of the time), 2 (symptom present to considerable degree, or good part of the time), 3 (symptom present very much, or most of the time). Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 2. Negative self-evaluation (comparative self-criticism and internalised self-criticism) measured by the Levels of Self-Criticism Scale (LOSC). 22 items, each scored 1 - 7 (strongly disagree to strongly agree), giving a total score of 22 - 154. Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 3. Means of coping with negative mood and regulating emotional state measured by the Distress Tolerance Scale (DTS). 20 items, each scored 1 - 5 (never to all the time), giving a total score of 20 - 100. Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 4. Beliefs about expressing emotions, coping with emotions and validity of emotions measured by the Beliefs About Emotions Questionnaire. 12 items, for each score 1 - 7 (totally agree to totally disagree). Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 5. Submissive behaviour measured by the Submissive Behaviour Scale (SBS). 16 items, measured on scale 0 - 4 (0 = never, 1 = rarely, 2 = sometimes, 3 = mostly, 4 = always), giving total score 0 - 64. Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 6. Ruminative Response Style Scale of the response Styles Questionnaire (RSQ). 22 items, measured on scale 0 - 4 (0 = never, 1 = rarely, 2 = sometimes, 3 = mostly, 4 = always), giving total score 0 - 88. Completed at	—

Measure

Time frame

1. Symptoms of depression, anxiety and stress, respectively, measured by the Depression Anxiety and Stress Scales (DASS-21). 21 items, each scored 0 - 3, giving total score of 0 - 63. Comprised of 3 scales (7 items each) for depression, anxiety and stress scoring 0 - 21, respectively. For each item score represents 0 (no symptom at all), 1 (symptom present to some degree, or some of the time), 2 (symptom present to considerable degree, or good part of the time), 3 (symptom present very much, or most of the time). Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 2. Negative self-evaluation (comparative self-criticism and internalised self-criticism) measured by the Levels of Self-Criticism Scale (LOSC). 22 items, each scored 1 - 7 (strongly disagree to strongly agree), giving a total score of 22 - 154. Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 3. Means of coping with negative mood and regulating emotional state measured by the Distress Tolerance Scale (DTS). 20 items, each scored 1 - 5 (never to all the time), giving a total score of 20 - 100. Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 4. Beliefs about expressing emotions, coping with emotions and validity of emotions measured by the Beliefs About Emotions Questionnaire. 12 items, for each score 1 - 7 (totally agree to totally disagree). Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 5. Submissive behaviour measured by the Submissive Behaviour Scale (SBS). 16 items, measured on scale 0 - 4 (0 = never, 1 = rarely, 2 = sometimes, 3 = mostly, 4 = always), giving total score 0 - 64. Completed at pre-treatment, end of treatment (4 months) and follow-up (6 months). 6. Ruminative Response Style Scale of the response Styles Questionnaire (RSQ). 22 items, measured on scale 0 - 4 (0 = never, 1 = rarely, 2 = sometimes, 3 = mostly, 4 = always), giving total score 0 - 88. Completed at

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026